COSCIENS BIOPHARMA INC. reports a Return on Equity (ROE) of -265.34%.

What is CSCI's dividend yield?

COSCIENS BIOPHARMA INC. offers a dividend yield of 0.00%.

What is CSCI's Deepscope Quality Score?

Deepscope rates CSCI's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CSCI?

Deepscope's AI Timing Score for CSCI is 6 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CSCI belong to?

COSCIENS BIOPHARMA INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

CSCI (NASDAQ) 株価分析 | COSCIENS BIOPHARMA INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-10 | FS: 2025-06-30)

CSCI

COSCIENS BIOPHARMA INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 2.81

0.09 (3.31%) Day Change

Watchlist Portfolio Compare Chart

0.06

D/E

-265.3%

ROE

-68.3%

ROA

0.00%

Div Yield

COSCIENS BIOPHARMA INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.81 Price 0.09 (3.31%) Day Change	NEWS SCORE: 89

CSCI, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Deepscope 分析

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.81
PBV / Sector	1.22 / 4.79 GOOD
Earning Per Share	-6.12

PE / Sector	N/A / 17.89
PEG or PE/Growth / Sector	N/A / 0.56
Average 1M Daily Value	3657.756500000000
Average 1W Daily Value	7341.092000000000

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-199.53 / 468.85
NPM Average (%) / Sector	-63.23 / -1,531.69
NPM Change Average (%) / Sector	-19.50 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-68.33 / 31.69
ROA Average (%) / Sector	-20.68 / -353.18
ROA Change Average (%) / Sector	12.51 / 5,214.65 GOOD
ROE (%) / Sector	-265.34 / 10.58
ROE Average (%) / Sector	-74.32 / 27.64
ROE Change Average (%) / Sector	133.82 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

登録情報

Analyze Date	2026-06-11 09:54:42
Symbol	CSCI
Name	COSCIENS BIOPHARMA INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	3.18 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	8.64 / 8,963.32

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 222 Bay Street, Toronto, ON, Canada, M5K 1E7

Phone: -

Website: https://www.cosciensbio.com

Sector: Healthcare >> Biotechnology

Description: COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce inflammation for the healthcare and cosmetic industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as for endocrinology and oncology indications. The company sells its products through its distribution network. It has license agreements with Pharmanovia, MegaPharm Ltd., ER Kim Pharmaceuticals Bulgaria Eood, and NK MEDITECH Ltd, as well as Agriculture Canada and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.